Lactobacillus Acidophilus LA1 (10 billion CFU)

10B CFU's coming from one of the most world's most scientifically researched Probiotic species, Lactobacillus acidophilus.

Probiotics must survive stomach acid if they are to reach the small intestine and colonize the gut. We specifically selected Lactobacillus acidophilus as it's scientifically proven to be hardy and intrinsically resistant to stomach acid. 

L.acidophilus has also been shown to help relieve IBS symptoms, including abdominal pain, gas, and bowel irregularity and can help reduce gut inflammation caused by “leaky gut”.

Sources: 

“Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome”, by Dong Hyun Sinn et al., 2008 Oct;53(10):2714-8.

Lyra, A., Hillilä, M., Huttunen, T., et al. (2016). Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World journal of gastroenterology, 22(48), 10631–10642. 

Maixent, J. M., Pons, O., Sennoune, S. R., & Sadrin, S. (2020). Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives. Cellular and molecular biology (Noisy-le-Grand, France), 66(3), 211–214.

Rousseaux, C., Thuru, X., Gelot, A., et al. (2007). Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature medicine, 13(1), 35–37.

Rana Al-Sadi et. al (2021) Lactobacillus acidophilus Induces a Strain-specific and Toll-Like Receptor 2–Dependent Enhancement of Intestinal Epithelial Tight Junction Barrier and Protection Against Intestinal Inflammation. American Journal of Pathology, Volume 191, Issue 5, P872-884.